Stay updated with breaking news from Controlled Equity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel™ in patients with Fragile X syndrome; topline results expected first-half 2024 European Commission granted... | March 28, 2023
Investegate announcements from Nyxoah, Nyxoah Raises $3 Million from an At-the-Market Equity Offering
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Raises $3 Million from an At-the-Market Equity Offering Mont-Saint-Guibert, Belgium – March 27, 2023,...
Toronto, Ontario--(Newsfile Corp. - January 6, 2023) - Seabridge Gold Inc. (TSX: SEA) (NYSE: SA) (the "Company" or "Seabridge") announces that it has entered into a Controlled Equity OfferingSM Sales
14.11.2022 - Enrollment continues in RECONNECT, a confirmatory pivotal Phase 3 trial of Zygel in patients with Fragile X syndrome (FXS); topline results expected second-half 2023 $55.9 million in cash and cash equivalents at September 30, 2022; Cash runway into ...